Which medication wins the battle in COPD?

There is always one drugs trying to stake its place as being better than another. A new report suggests that tiotropium (Spiriva) may be “better” than a rival long-acting bronchodilator, salmetrol (Serevent), in a head-to-head comparison. What the “battle” was about was the length of time to having an exacerbation of COPD related symptoms (cough, sputum production, bronchitis, etc). The tiotropium brand had a longer time to exacerbation (187 days) than the salmetrol (145 days).

One word of caution, however, was ...

Continue Reading →

New therapy for asthma?

A new therapy for the management of uncontrolled asthma has now been proposed in a recent article in the New England Journal of Medicine. In the September edition, 2001, an article appeared which has stirred the interest amongst pulmonologist. Stephen Peters, MD, of Wake Forest University Baptist Medical Center in Winston-Salem, North Carolina, was the principal investigator. The study was released by the US National Heart, Lung, and Blood Institute.
The patients evaluated were on low dose inhaled corticosteroids (beclomethasone ...

Continue Reading →